Report overview
Diabetes mellitus (DM) is often referred as diabetes and also described as a group of metabolic diseases which involved with the hormone insulin. In diabetes, the blood glucose or the blood sugar level is very high. Over time, having a high level of sugar or glucose in the blood causes severe health problems. There are three types of diabetes such as type 1 diabetes, type 2 diabetes, and gestational diabetes. The type 1 diabetes usually occurs in children and young adults whether type 2 diabetes is usually developed in any age group. Type 2 diabetes is the most commonly occurred type of diabetes. The gestational diabetes is developed in some women at pregnancy time which is temporary and subsidized after the child birth. There are various disposable devices used for the diagnosis of blood glucose and uptake of insulin to maintain the blood glucose level. The diabetes diagnosis is normally done by a simple blood test Hemoglobin A1c test, random blood sugar test, fasting blood sugar test and oral glucose tolerance test.
This report contains market size and forecasts of Disposable Diabetes Devices in global, including the following market information:
Global Disposable Diabetes Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Disposable Diabetes Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Disposable Diabetes Devices companies in 2021 (%)
The global Disposable Diabetes Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Diagnostics Devices Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Disposable Diabetes Devices include Bayer Healthcare, Abbott Laboratories, Johnson& Johnson, Becton Dickinson, F.Hoffmann La-Roche, Novo Nordisk, Medtronic, Sanofi and ARKRAY and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Disposable Diabetes Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Disposable Diabetes Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Disposable Diabetes Devices Market Segment Percentages, by Type, 2021 (%)
Diagnostics Devices
Delivery Devices
Global Disposable Diabetes Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Disposable Diabetes Devices Market Segment Percentages, by Application, 2021 (%)
Hospitals Pharmacies
Retail Pharmacies
E-Commerce
Global Disposable Diabetes Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Disposable Diabetes Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Disposable Diabetes Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Disposable Diabetes Devices revenues share in global market, 2021 (%)
Key companies Disposable Diabetes Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Disposable Diabetes Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer Healthcare
Abbott Laboratories
Johnson& Johnson
Becton Dickinson
F.Hoffmann La-Roche
Novo Nordisk
Medtronic
Sanofi
ARKRAY
Terumo
